Movement Alert｜WUXI XDC Falls 3.76% in Regular Trading, Life Sciences Tools & Services Weakness Weighs on Shares

Market Focus10-27 10:06

On October 27, WUXI XDC fell 3.76% in regular trading, trading at HK$68.55, with turnover of HK$200 million.

The move aligns with broader weakness across the Life Sciences Tools & Services segment rather than a new company-specific negative catalyst. In the same sector, WUXI BIO fell 4.66%, INSILICO fell 1.32%, WUXI APPTEC fell 0.85%, and XTALPI fell 0.16%, while GENSCRIPT B-1K rose 3.97%.

Recent disclosed fundamentals remain solid: first-half revenue was RMB3.701 billion, up 37.0% year over year, while adjusted net profit rose 37.4% to RMB1.027 billion. Separately, brokers previously maintained a Buy view with a HK$97.90 target price, citing a potential FDA inspection of the Wuxi facility in the first quarter of next year as a key commercialization milestone.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment